Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

Cunningham N, Cutts RJ, Swift C, Coakley M, Sritharan P, Dunne K, Dewan M, Kilburn L, Goddard K, Hall P, Harper-Wynne C, Macpherson IR, Okines A, Wardley A, Waters S, Palmieri C, Winter M, Bliss J, Garcia-Murillas I, Turner NC

Open source

DOI: 10.1001/jamaoncol.2026.2833
Published: 2026 Aug 13
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2026.2833,
  title = {Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.},
  author = {Cunningham N and Cutts RJ and Swift C and Coakley M and Sritharan P and Dunne K and Dewan M and Kilburn L and Goddard K and Hall P and Harper-Wynne C and Macpherson IR and Okines A and Wardley A and Waters S and Palmieri C and Winter M and Bliss J and Garcia-Murillas I and Turner NC},
  year = {2026},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2026.2833},
  url = {https://doi.org/10.1001/jamaoncol.2026.2833}
}

RIS

TY  - JOUR
TI  - Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.
AU  - Cunningham N
AU  - Cutts RJ
AU  - Swift C
AU  - Coakley M
AU  - Sritharan P
AU  - Dunne K
AU  - Dewan M
AU  - Kilburn L
AU  - Goddard K
AU  - Hall P
AU  - Harper-Wynne C
AU  - Macpherson IR
AU  - Okines A
AU  - Wardley A
AU  - Waters S
AU  - Palmieri C
AU  - Winter M
AU  - Bliss J
AU  - Garcia-Murillas I
AU  - Turner NC
PY  - 2026
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2026.2833
UR  - https://doi.org/10.1001/jamaoncol.2026.2833
ER  -

APA

N, C., RJ, C., C, S., M, C., P, S., K, D., M, D., L, K., K, G., P, H., C, H., IR, M., A, O., A, W., S, W., C, P., M, W., J, B., I, G., & NC, T. (2026). Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2026.2833

Source records

pubmed · retrieved 2026-09-26T09:00:53.306Z